Curriculum Development Committee
The Diabetes Masters Program is a highly engaging and dynamic regional meeting designed to help healthcare professionals provide individualized antihyperglycemic treatment for their patients at risk for or diagnosed with type 2 diabetes mellitus (T2DM). Because optimal diabetes care requires collaboration among professionals across multiple healthcare disciplines—including endocrinologists, diabetologists, diabetes-treating primary care physicians, diabetes educators, nurses, and pharmacists—this activity aims to encourage a multidisciplinary, collaborative approach to diabetes care.
The program will begin with a brief, introductory general session that will provide an overview of how to individualize management of hyperglycemia and weight in T2DM. Participants will then be divided into small groups, assigned a specific case study, and asked to consider that case throughout a series of highly interactive breakout sessions. The breakout discussions will review and evaluate the most recent evidence regarding clinical applications of newer and emerging therapies, such as dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), sodium glucose cotransporter 2 (SGLT2) inhibitors, and new insulin analogues for the treatment of T2DM.
Following the breakout sessions, each group will develop an individualized treatment plan for their assigned case study. The treatment plans will be presented to the expert faculty and all participants, who will score each group’s presentation according to predetermined criteria. The group with the best case presentation will be awarded the “Diabetes Masters Certificate” during the closing awards ceremony.
Additional dates are anticipated in the fall. Please check back regularly for any updates!